Theravance MRSA drug a victim of Ben Venue shutdown - FiercePharma Manufacturing.
Vibativ, an injectable skin-infection treatment from Theravance ($THRX) that's marketed by Astellas, has fallen victim to the QA-related production shutdown at contractor Ben Venue's plant in Bedford, OH. Theravance spokesperson Cheryllyn De Ocampo confirmed by email the speculation in Friday's San Francisco Business Times.
